⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEXX News
Lexaria Bioscience Corp. Common Stock
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
accessnewswire.com
LEXX
LEXXW
Lexaria Bioscience Corp. Provides Strategic Update
accessnewswire.com
LEXX
LEXXW
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
accessnewswire.com
LEXX
LEXXW
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
accessnewswire.com
LEXX
LEXXW